Sign In

Michelle Kim-Danely

Chief Development Officer @ ALPHA10X

Dr. Michelle Kim-Danely holds a Ph.D. in Molecular Neuroscience from Columbia University in the City of New York, where she focused on biochemistry and molecular biophysics. She also studied Biological Sciences at Cornell University, College of Arts and Sciences. Dr. Kim-Danely has a rich and extensive background in various organizations, holding significant roles such as Chief Development Officer at ALPHA10X. Previously, she served as a Startup advisor and consultant at an undisclosed firm, as well as in leadership positions at Autobahn Labs, Inc., Biodesy, Inc., and Vium, which was later acquired by Recursion. Her experience also includes roles at UCSF, Breakout Labs / Thiel Foundation, and research positions at FibroGen and Roche Pharmaceuticals.

Michelle Kim-Danely
Add to my network

Location

Santa Barbara, California, United States